Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 19c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.39), $0.19 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• S&P shares jump report of potential CapIQ spinout
• Active options: AAPL NVDA TSLA MU AMZN META SPCX INTC MSFT ORCL
• Reports Of Blasts Across Iran's Southern Regions: State TV - Bloomberg